MotionHall provides a cloud‑based platform that builds a digital twin of the global biopharma ecosystem by aggregating patents, clinical trial, regulatory and market data. Its AI‑driven analytics and integrated consulting layer deliver valuation models, competitive gap analysis, and transaction scenario simulations for senior executives managing IP portfolios and M&A strategies. Users access insights via an interactive dashboard with collaborative tools and export capabilities.
Funding
Funding not disclosed
Founders
Product
Problem
Biopharma companies often struggle to obtain a comprehensive, up‑to‑date view of the global drug development and IP landscape, making it difficult for senior executives to evaluate portfolio value, identify acquisition targets, and optimize transaction strategies.
Solution
MotionHall delivers a cloud‑based platform that creates a digital twin of the worldwide biopharma ecosystem, integrating public and proprietary datasets on patents, pipelines, clinical outcomes, and market activity. The platform applies data‑science models to surface competitive gaps, forecast asset value, and simulate transaction scenarios. Human consultants embed industry expertise into the workflow, translating analytical outputs into actionable recommendations for IP portfolio optimization and M&A planning. Executives access the insights through an interactive dashboard that supports real‑time querying, collaborative annotation, and export to standard reporting formats.
Target Audience
Primary users are senior biopharma executives, corporate development leaders, and IP portfolio managers who need data‑backed insights for strategic planning, M&A, and licensing decisions.
Features
- Proprietary digital twin that continuously aggregates patent filings, clinical trial data, regulatory approvals, and market performance across all therapeutic areas
- AI‑driven analytics engine for valuation modeling, competitive mapping, and scenario simulation of IP and transaction outcomes
- Integrated IP portfolio management tools that visualize asset coverage, overlap, and expiration risk across the global landscape
- Transaction intelligence module that ranks potential acquisition or licensing targets based on strategic fit and financial metrics
- Collaborative web interface with role‑based access, annotation capabilities, and export to PowerPoint or Excel for board‑level presentations
- Secure, HIPAA‑compliant cloud infrastructure with API connectors for ingesting internal R&D and licensing data
- Embedded senior strategy consulting layer that provides contextual interpretation of model outputs and best‑practice guidance